Scopus
🔓 Açık Erişim YÖKSİS DOI Eşleşti
SJR Q1
Incidence and predictors of early seizures in intracerebral haemorrhage and the effect of tranexamic acid
European Stroke Journal · Haziran 2020
Özet
Introduction: Seizures are common after intracerebral haemorrhage. Tranexamic acid increases the risk of seizures in non-intracerebral haemorrhage population but its effect on post-intracerebral haemorrhage seizures is unknown. We explored the risk factors and outcomes of seizures after intracerebral haemorrhage and if tranexamic acid increased the risk of seizures in the Tranexamic acid for IntraCerebral Haemorrhage-2 trial. Patients and methods: Seizures were reported prospectively up to day 90. Cox regression analyses were used to determine the predictors of seizures within 90 days and early seizures (≤7 days). We explored the effect of early seizures on day 90 outcomes. Results: Of 2325 patients recruited, 193 (8.3%) had seizures including 163 (84.5%) early seizures and 30 (15.5%) late seizures (>7 days). Younger age (adjusted hazard ratio (aHR) 0.98 per year increase, 95% confidence interval (CI) 0.97–0.99; p = 0.008), lobar haematoma (aHR 5.84, 95%CI 3.58–9.52; p < 0.001), higher National Institute of Health Stroke Scale (aHR 1.03, 95%CI 1.01–1.06; p = 0.014) and previous stroke (aHR 1.66, 95%CI 1.11–2.47; p = 0.013) were associated with early seizures. Tranexamic acid did not increase the risk of seizure within 90 days. Early seizures were associated with worse modified Rankin Scale (adjusted odds ratio (aOR) 1.79, 95%CI 1.12–2.86, p = 0.015) and increased risk of death (aOR 3.26, 95%CI 1.98–5.39; p < 0.001) at day 90. Discussion and conclusion: Lobar haematoma was the strongest independent predictor of early seizures after intracerebral haemorrhage. Tranexamic acid did not increase the risk of post-intracerebral haemorrhage seizures in the first 90 days. Early seizures resulted in worse functional outcome and increased risk of death.
YÖKSİS Kayıtları
Incidence and predictors of early seizures in intracerebral haemorrhage and the effect of tranexamic acid
European Stroke Journal · 2020 ESCI, Pubmed
Prof. Dr. ŞEREFNUR ÖZTÜRK →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 1 kaydı bulundu.
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 1 kaydı bulundu.
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial
2016 ISSN: 2396-9873 ESCI
Prof. Dr. ŞEREFNUR ÖZTÜRK →
Makale Bilgileri
Dergi
European Stroke Journal
Toplam Atıf
21 atıf
· Scopus
ISSN23969873
Yayın TarihiHaziran 2020
Cilt / Sayfa5 · 123-129
Scopus ID2-s2.0-85078079987
Erişim🔓 Açık Erişim
Kurumlar
Nottingham University Hospitals NHS Trust
Nottingham United Kingdom
Selçuk Üniversitesi
Selçuklu Turkey
Tallaght University Hospital
Dublin Ireland
Tbilisi State Medical University
Tbilisi Georgia
The University of Western Australia
Perth Australia
Universiti Kebangsaan Malaysia
Bangi Malaysia
University Hospitals of Leicester NHS Trust
Leicester United Kingdom
University of Nottingham
Nottingham United Kingdom
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 21.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
European Stroke Journal
Q1
SJR Skoru1,886
H-Index45
YayıncıSAGE Publications Inc.
ÜlkeUnited Kingdom
Cardiology and Cardiovascular Medicine (Q1)
Neurology (clinical) (Q1)
Metrikler
21
Atıf